株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

医薬品およびCMO市場:製品別 (APIおよび原料、最終剤形、医薬品パッケージング) - ラテンアメリカの業界分析、規模、シェア、成長、動向、予測

Pharmaceutical Products and CMO Market: (Product Type - API and Ingredients, Finished Dosage Form, and Pharmaceutical Packaging) - LATAM Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

発行 Transparency Market Research 商品コード 374695
出版日 ページ情報 英文 156 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.59円で換算しております。
Back to Top
医薬品およびCMO市場:製品別 (APIおよび原料、最終剤形、医薬品パッケージング) - ラテンアメリカの業界分析、規模、シェア、成長、動向、予測 Pharmaceutical Products and CMO Market: (Product Type - API and Ingredients, Finished Dosage Form, and Pharmaceutical Packaging) - LATAM Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
出版日: 2016年08月31日 ページ情報: 英文 156 Pages
概要

当レポートでは、ラテンアメリカの医薬品およびCMO市場について調査し、市場の概要と今後の予測、競合動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 序論

第2章 仮定と調査方法

第3章 エグゼクティブサマリー

第4章 業界概要

  • 製品概要
  • 業界動向
  • 医薬品製造委託規制

第5章 市場動向

  • 促進因子:医薬品市場
  • 阻害因子:医薬品市場
  • 機会:医薬品市場
  • 促進因子:CMO市場
  • 阻害因子:CMO市場
  • 機会:CMO市場
  • 機会分析
  • ポーターズ分析
  • バリューチェーン分析

第6章 製品別市場分析

  • 主な調査結果
  • イントロダクション
  • 製品別医薬品市場価値シェア分析
  • 製品別医薬品市場規模分析
  • 製品別医薬品市場の魅力度分析
  • 製品別CMO市場価値シェア分析
  • 製品別CMO市場規模分析
  • 製品別CMO市場の魅力度分析
  • 主な動向

第7章 国別市場分析

  • 国別医薬品市場価値シェア分析
  • 国別医薬品市場予測
  • 国別医薬品市場の魅力度分析
  • 国別CMO市場価値シェア分析
  • 国別CMO市場予測

第8章 メキシコ市場

第9章 ブラジル市場

第10章 ベネズエラ市場

第11章 アルゼンチン市場

第12章 その他のラテンアメリか諸国市場

第13章 企業プロファイル

  • 競合マトリクス
  • BASF SE
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Pisa Farmaceutica
  • Fresenius SE & Co. KGaA
  • 武田薬品工業株式会社
  • Ferring Pharmaceuticals, Inc.
  • Landsteiner Scientific

図表

目次

This report on the pharmaceutical products and CMO market analyzes the current and future market scenario in Latin America. Most pharmaceutical companies are gradually outsourcing manufacturing activities to contract manufacturers in order to achieve efficiencies in cost, quality, capacity, and time to market or to obtain specific expertise in particular business category, which is not available in-house. Moreover, increasing cost pressures, cost benefits, and inclination of pharmaceutical companies to focus on core competencies such as R&D and marketing has created a need for pharmaceutical contract manufacturing outsourcing.

The Latin America pharmaceutical products and CMO market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to the segments based on product type and countries. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises Porters Five Forces Analysis for the CMO market in order to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by country, thus presenting a thorough analysis of the overall competitive scenario in the pharmaceutical products and CMO market in Latin America.

Based on product type, the market has been segmented into API and ingredients, finished dosage form (FDF), and pharmaceutical packaging. The market segments have been extensively analyzed based on available approved drugs, prevalence of the diseases, available patent of drugs, regulatory access, and geographical coverage in LATAM. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Geographically, the pharmaceutical products and CMO market in Latin America has been categorized into five major countries: Brazil, Mexico, Argentina, Venezuela, and Rest of Latin America. The market size and forecast for each of these countries have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year. The research study also covers the competitive scenario in these regions.

The report also profiles major players in the pharmaceutical and CMO market in the region based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Bayer AG, Novartis AG, Merck & Co., Inc., GSK plc, F. Hofmann La Roche, BASF SE, Boehringer Ingelheim Group, Pisa Farmacéutica, Fresenius SE & Co. KGaA, Takeda Pharmaceutical Company Limited, Ferring Pharmaceuticals, and Inc., Landsteiner Scientific.

The pharmaceutical products and CMO Market in Latin America has been segmented as given below:

LATAM Pharmaceutical Products and CMO Market, by Product Type

  • API and Ingredients
  • Finished Dosage Form (FDF)
  • Pharmaceutical Packaging

LATAM Pharmaceutical Products and CMO Market, by Country

  • Brazil
    • API and Ingredients
    • Finished Dosage Form (FDF)
    • Pharmaceutical Packaging
  • Mexico
    • API and Ingredients
    • Finished Dosage Form (FDF)
    • Pharmaceutical Packaging
  • Venezuela
    • API and Ingredients
    • Finished Dosage Form (FDF)
    • Pharmaceutical Packaging
  • Argentina
    • API and Ingredients
    • Finished Dosage Form (FDF)
    • Pharmaceutical Packaging
  • Rest of Latin America
    • API and Ingredients
    • Finished Dosage Form (FDF)
    • Pharmaceutical Packaging

Table of Contents

Section 1: Preface

  • 1.1. Report Scope
  • 1.2. Research Objective

Section 2: Assumptions and Research Methodology

Section 3: Executive Summary

Section 4: Market Overview

  • 4.1. Product Overview
  • 4.2. Key Industry Developments
  • 4.3. Contract Manufacturing Regulations

Section 5: Market Dynamics

  • 5.1. Drivers - Pharmaceutical Products Market
  • 5.2. Restraints - Pharmaceutical Products Market
  • 5.3. Opportunities - Pharmaceutical Products Market
  • 5.4. Drivers - CMO Market
  • 5.5. Restraints - CMO Market
  • 5.6. Opportunities - CMO Market
  • 5.7. Opportunity Analysis
  • 5.8. Porter's Analysis
  • 5.9. Value Chain Analysis

Section 6: LATAM Pharmaceutical Products and CMO Market Analysis, by Product Type

  • 6.1. Key Findings
  • 6.2. Introduction
  • 6.3. LATAM Pharmaceutical Products Market Value Share Analysis By Product Type, 2015 and 2024
  • 6.4. LATAM Pharmaceutical Products Market Size (US$ Mn) Forecast By Product Type, 2014-2024
  • 6.5. LATAM Pharmaceutical Products Market Analysis, by Product Type (1/7)
  • 6.6. LATAM Pharmaceutical Products Market Attractiveness Analysis, by Product Type
  • 6.7. LATAM CMO Market Size (US$ Mn) Forecast By Product Type, 2014-2024
  • 6.8. Latin America CMO Market Value Share Analysis By Product Type, 2015 and 2024
  • 6.9. LATAM CMO Market Analysis, by Product Type
  • 6.10. LATAM CMO Market Attractiveness Analysis, by Product Type
  • 6.11. Key Trends

Section 7: LATAM Pharmaceutical Products and CMO Market Analysis, by Country

  • 7.1. Latin America Pharmaceutical Products Market Value Share Analysis, by Country
  • 7.2. Pharmaceutical Products Market Forecast, by Country
  • 7.3. Pharmaceutical Products Market Attractiveness Analysis, by Country, 2015
  • 7.4. Latin America CMO Market Value Share Analysis, by Country, 2015 and 2024
  • 7.5. Latin America CMO Market Forecast, by Country

Section 8: Mexico Pharmaceutical Products and CMO Market Analysis

  • 8.1. Key Findings
  • 8.2. Mexico Pharmaceutical Products Market Overview
  • 8.3. Mexico Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
  • 8.4. Mexico Market Forecast, by Product
  • 8.5. Mexico Market Attractiveness Analysis
  • 8.6. Mexico CMO Market Overview
  • 8.7. Mexico CMO Market Value Share Analysis, by Product, 2015 and 2024
  • 8.8. Mexico CMO Market Forecast, by Product
  • 8.9. Mexico CMO Market Attractiveness Analysis, by Product, 2015
  • 8.10. Market Trends

Section 9: Brazil Pharmaceutical Products and CMO Market Analysis

  • 9.1. Key Findings
  • 9.2. Brazil Pharmaceutical Products Market Overview
  • 9.3. Brazil Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
  • 9.4. Brazil Market Forecast, by Product
  • 9.5. Brazil Market Attractiveness Analysis
  • 9.6. Brazil CMO Market Overview
  • 9.7. Brazil CMO Market Value Share Analysis, by Product, 2015 and 2024
  • 9.8. Brazil CMO Market Forecast, by Product
  • 9.9. Brazil CMO Market Attractiveness Analysis, by Product, 2015
  • 9.10. Market Trends

Section 10: Venezuela Pharmaceutical Products and CMO Market Analysis

  • 10.1. Key Findings
  • 10.2. Venezuela Pharmaceutical Products Market Overview
  • 10.3. Venezuela Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
  • 10.4. Venezuela Market Forecast, by Product
  • 10.5. Venezuela Market Attractiveness Analysis
  • 10.6. Venezuela CMO Market Overview
  • 10.7. Venezuela CMO Market Value Share Analysis, by Product, 2015 and 2024
  • 10.8. Venezuela CMO Market Forecast, by Product
  • 10.9. Venezuela CMO Market Attractiveness Analysis, by Product, 2015
  • 10.10. Market Trends

Section 11: Argentina Pharmaceutical Products and CMO Market Analysis

  • 11.1. Key Findings
  • 11.2. Argentina Pharmaceutical Products Market Overview
  • 11.3. Argentina Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
  • 11.4. Argentina Market Forecast, by Product
  • 11.5. Argentina Market Attractiveness Analysis
  • 11.6. Argentina CMO Market Overview
  • 11.7. Argentina CMO Market Value Share Analysis, by Product, 2015 and 2024
  • 11.8. Argentina CMO Market Forecast, by Product
  • 11.9. Argentina CMO Market Attractiveness Analysis, by Product, 2015
  • 11.10. Market Trends

Section 12: Rest of Latin America Pharmaceutical Products and CMO Market Analysis

  • 12.1. Key Findings
  • 12.2. Rest of Latin America Pharmaceutical Products Market Overview
  • 12.3. Rest of Latin America Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
  • 12.4. Rest of Latin America Market Forecast, by Product
  • 12.5. Rest of Latin America Market Attractiveness Analysis
  • 12.6. Rest of Latin America CMO Market Overview
  • 12.7. Rest of Latin America CMO Market Value Share Analysis, by Product, 2015 and 2024
  • 12.8. Rest of Latin America CMO Market Forecast, by Product
  • 12.9. Rest of Latin America CMO Market Attractiveness Analysis, by Product, 2015
  • 12.10. Market Trends

Section 13: Company Profiles

  • 13.1. Competition Matrix
  • 13.2. BASF SE
    • 13.2.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 13.2.2. Financial Overview
    • 13.2.3. Product Portfolio
    • 13.2.4. SWOT Analysis
    • 13.2.5. Strategic Overview
  • 13.3. Bayer AG
    • 13.3.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 13.3.2. Financial Overview
    • 13.3.3. Product Portfolio
    • 13.3.4. SWOT Analysis
    • 13.3.5. Strategic Overview
  • 13.4. Boehringer Ingelheim GmbH
    • 13.4.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 13.4.2. Financial Overview
    • 13.4.3. Product Portfolio
    • 13.4.4. SWOT Analysis
    • 13.4.5. Strategic Overview
  • 13.5. F. Hoffmann-La Roche Ltd.
    • 13.5.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 13.5.2. Financial Overview
    • 13.5.3. Product Portfolio
    • 13.5.4. SWOT Analysis
    • 13.5.5. Strategic Overview
  • 13.6. Merck & Co., Inc.
    • 13.6.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 13.6.2. Financial Overview
    • 13.6.3. Product Portfolio
    • 13.6.4. SWOT Analysis
    • 13.6.5. Strategic Overview
  • 13.7. Novartis AG
    • 13.7.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 13.7.2. Financial Overview
    • 13.7.3. Product Portfolio
    • 13.7.4. SWOT Analysis
    • 13.7.5. Strategic Overview
  • 13.8. Pfizer, Inc.
    • 13.8.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 13.8.2. Financial Overview
    • 13.8.3. Product Portfolio
    • 13.8.4. SWOT Analysis
    • 13.8.5. Strategic Overview
  • 13.9. Pisa Farmacéutica
    • 13.9.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 13.9.2. Financial Overview
    • 13.9.3. Product Portfolio
    • 13.9.4. SWOT Analysis
    • 13.9.5. Strategic Overview
  • 13.10. Fresenius SE & Co. KGaA
    • 13.10.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 13.10.2. Financial Overview
    • 13.10.3. Product Portfolio
    • 13.10.4. SWOT Analysis
    • 13.10.5. Strategic Overview
  • 13.11. Takeda Pharmaceutical Company Limited
    • 13.11.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 13.11.2. Financial Overview
    • 13.11.3. Product Portfolio
    • 13.11.4. SWOT Analysis
    • 13.11.5. Strategic Overview
  • 13.12. Ferring Pharmaceuticals, Inc.
    • 13.12.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 13.12.2. Financial Overview
    • 13.12.3. Product Portfolio
    • 13.12.4. SWOT Analysis
    • 13.12.5. Strategic Overview
  • 13.13. Landsteiner Scientific
    • 13.13.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 13.13.2. Financial Overview
    • 13.13.3. Product Portfolio
    • 13.13.4. SWOT Analysis
    • 13.13.5. Strategic Overview

List of Figures

  • FIG. 1: LATAM Pharmaceutical Products Market Value Share Analysis, by Product Type, 2015 and 2024
  • FIG. 2: LATAM API and Ingredients Market Revenue (US$ Mn), 2014-2024
  • FIG. 3: LATAM Finished Dosage Form Market Revenue (US$ Mn), 2014-2024
  • FIG. 4: LATAM Pharmaceutical Packaging Market Revenue (US$ Mn), 2014-2024
  • FIG. 5: LATAM Pharmaceutical Products Market Attractiveness Analysis, by Product Type
  • FIG. 6: LATAM CMO Market Value Share Analysis By Product Type, 2015 and 2024
  • FIG. 7: LATAM API and Ingredients Market Revenue (US$ Mn), 2014-2024
  • FIG. 8: LATAM API and Ingredients Market Revenue (US$ Mn), 2014-2024
  • FIG. 9: LATAM Pharmaceutical Packaging Market Revenue (US$ Mn), 2014-2024
  • FIG. 10: LATAM CMO Market Attractiveness Analysis, by Product Type
  • FIG. 11: Latin America Pharmaceutical Products Market Value Share Analysis, by Country, 2015 and 2024
  • FIG. 12: Pharmaceutical Products Market Attractiveness Analysis, by Country, 2015
  • FIG. 13: Latin America Market Value Share Analysis,
  • FIG. 14: Mexico Pharmaceutical Products Market Size (US$ Mn) Forecast, 2014-2024
  • FIG. 15: Mexico Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
  • FIG. 16: Mexico Pharmaceutical Products Market Attractiveness Analysis, by Product, 2015
  • FIG. 17: Mexico CMO Market Size (US$ Mn) Forecast, 2014-2024
  • FIG. 18: Mexico CMO Market Attractiveness Analysis, by Product
  • FIG. 19: Mexico CMO Market Value Share Analysis, by Product, 2015 and 2024
  • FIG. 20: Mexico CMO Market Attractiveness Analysis, By Product, 2015
  • FIG. 21: Brazil Pharmaceutical Products Market Size (US$ Mn) Forecast, 2014-2024
  • FIG. 22: Brazil Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
  • FIG. 23: Brazil Pharmaceutical Products Market Attractiveness Analysis, by Product, 2015
  • FIG. 24: Brazil CMO Market Size (US$ Mn) Forecast, 2016-2024
  • FIG. 25: Brazil CMO Market Value Share Analysis, by Product, 2015 and 2024
  • FIG. 26: Brazil Market Attractiveness Analysis, by Product, 2015
  • FIG. 27: Venezuela Pharmaceutical Products Market Size (US$ Mn) Forecast, 2014-2024
  • FIG. 28: Venezuela Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
  • FIG. 29: Venezuela Pharmaceutical Products Market Attractiveness Analysis, by Product, 2015
  • FIG. 30: Venezuela CMO Market Size (US$ Mn) Forecast, 2016-2024
  • FIG. 31: Venezuela CMO Market Value Share Analysis, by Product, 2015 and 2024
  • FIG. 32: Venezuela CMO Market Attractiveness Analysis, by Product, 2015 and 2024
  • FIG. 33: Argentina Pharmaceutical Products Market Size (US$ Mn) Forecast, 2014-2024
  • FIG. 34: Argentina Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
  • FIG. 35: Argentina Pharmaceutical Products Market Attractiveness Analysis, by Product, 2015
  • FIG. 36: Argentina CMO Market Size (US$ Mn) Forecast, 2016-2024
  • FIG. 37: Argentina CMO Market Value Share Analysis,
  • FIG. 38: Argentina Market Attractiveness Analysis, by Product, 2015
  • FIG. 39: Rest of LATAM Pharmaceutical Products Market Size (US$ Mn) Forecast, 2014-2024
  • FIG. 40: Rest of LATAM Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
  • FIG. 41: Rest of LATAM Pharmaceutical Products Market Attractiveness Analysis, by Product, 2015
  • FIG. 42: Rest of LATAM CMO Market Value Share Analysis,
  • FIG. 43: Rest of LATAM Market Attractiveness Analysis, by Product, 2015

List of Tables

  • TABLE 1: LATAM Pharmaceutical Products Market Size (US$ Mn) Forecast, by Product Type, 2014-2024
  • TABLE 2: LATAM CMO Market Size (US$ Mn) Forecast, by Product Type, 2014-2024
  • TABLE 3: Latin America Pharmaceutical Products Market Size (US$ Mn) Forecast, by Country, 2016-2024
  • TABLE 4: Latin America Pharmaceutical Products Market Size (US$ Mn) Forecast, by Country, 2016-2024
  • TABLE 5: Mexico Pharmaceutical Products Market Size (US$ Mn) Forecast, by Product, 2014-2024
  • TABLE 6: Mexico CMO Market Size (US$ Mn) Forecast, by Product, 2016-2024
  • TABLE 7: Brazil Pharmaceutical Products Market Size (US$ Mn) Forecast, by Product, 2014-2024
  • TABLE 8: Brazil CMO Market Size (US$ Mn) Forecast, by Product, 2016-2024
  • TABLE 9: Venezuela Pharmaceutical Products Market Size (US$ Mn) Forecast, by Product, 2014-2024
  • TABLE 10: Venezuela CMO Market Size (US$ Mn) Forecast, by Product, 2016-2024
  • TABLE 11: Argentina Pharmaceutical Products Market Size (US$ Mn) Forecast, by Product, 2014-2024
  • TABLE 12: Argentina CMO Market Size (US$ Mn) Forecast, by Product, 2016-2024
  • TABLE 13: Rest of LATAM Pharmaceutical Products Market Size (US$ Mn) Forecast, by Product, 2014-2024
  • TABLE 14: Rest of LATAM CMO Market Size (US$ Mn) Forecast, by Product, 2016-2024
Back to Top